Gene and cell editing technologies are revolutionizing regenerative medicine by enabling precise DNA corrections and personalized therapies. Advances such as CRISPR-Cas9, base editors, and prime editors allow cures for genetic diseases like sickle cell anemia. Although challenges remain in delivery, safety, and ethics, ongoing innovations promise safer, more effective treatments in the near future.